Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Babak Hadian, Azita Zafarmohtashami, Zeinab Chaghervand & Negar Nouryazdan. (2022) Angiotensin-converting enzyme gene insertion/deletion polymorphism and hypertension disease. Archives of Physiology and Biochemistry 128:5, pages 1165-1169.
Read now
Read now
Maria Tamargo & Juan Tamargo. (2017) Future drug discovery in renin-angiotensin-aldosterone system intervention. Expert Opinion on Drug Discovery 12:8, pages 827-848.
Read now
Read now
Taposh Sarkar, Narinder Pal Singh, Premashish Kar, Syed Akhtar Husain, Seema Kapoor, Sunil Kumar Pollipalli, Anish Kumar & Neena Garg. (2016) Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients?. Renal Failure 38:5, pages 765-769.
Read now
Read now
Articles from other publishers (38)
Rubaiat Ahmed, Abdullah Al Saba, Anik Paul, Jasmin Nur, Md Sohrab Alam, Sajib Chakraborty, Md. Zakir Hossain Howlader, Laila N. Islam & A. H. M. Nurun Nabi. (2023) Intronic Variants of the Angiotensin-Converting Enzyme 2 Gene Modulate Plasma ACE2 Levels and Possibly Confer Protection against Severe COVID-19. BioMed Research International 2023, pages 1-14.
Crossref
Crossref
Anum Siraj, Saira Yahya, Amber Khan & Saleem Awan. (2023) ACE2 Receptor Polymorphism and its Correlation with Anti-SARS-CoV-2
IgM Antibodies - A Case-Control Study. Protein & Peptide Letters 30:2, pages 146-153.
Crossref
Crossref
Hongyin Chen, Jiangyun Peng, Tengyao Wang, Jielu Wen, Sifan Chen, Yu Huang & Yang Zhang. (2023) Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic. Biochemical Pharmacology 208, pages 115370.
Crossref
Crossref
Elham Assareh, Mohammad Amin Abbasi, Mahsa Heidari & S. Mohsen Asghari. (2023) A Review on COVID-19: Primary Receptor, Endothelial Dysfunction, Related Comorbidities, and Therapeutics. Iranian Journal of Science 47:1, pages 1-25.
Crossref
Crossref
Christian A. Devaux & Laurence Camoin-Jau. (2022) An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection. Frontiers in Microbiology 13.
Crossref
Crossref
Jun Wei Ng, Eric Tzyy Jiann Chong & Ping-Chin Lee. (2022) An Updated Review on the Role of Single Nucleotide Polymorphisms in
COVID-19 Disease Severity: A Global Aspect. Current Pharmaceutical Biotechnology 23:13, pages 1596-1611.
Crossref
Crossref
Yu-Si Luo, Lei Luo, Wei Li, Yan Chen, Guo-Feng Wu, Fang Chen, Hu-Yan Shen, Hong-Man Li, Ming-Yang Guo, Sha Yin, Ke Zhang & Zhong-Shan Cheng. (2022) Evaluation of a Functional Single Nucleotide Polymorphism of the SARS-CoV-2 Receptor ACE2 That Is Potentially Involved in Long COVID. Frontiers in Genetics 13.
Crossref
Crossref
Hooria Younas, Tahira Ijaz & Nakhshab Choudhry. (2022) Investigation of angiotensin-1 converting enzyme 2 gene (G8790A) polymorphism in patients of type 2 diabetes mellitus with diabetic nephropathy in Pakistani population. PLOS ONE 17:2, pages e0264038.
Crossref
Crossref
S. Abdelsattar, Z. A. Kasemy, S. F. Ewida, R. A. A. Abo-Elsoud, A. A. Zytoon, G. A. Abdelaal, A. S. Abdelgawad, F. O. Khalil & H. F. M. Kamel. (2022) ACE2 and TMPRSS2 SNPs as Determinants of Susceptibility to, and Severity of, a COVID-19 Infection. British Journal of Biomedical Science 79.
Crossref
Crossref
Thomas L. Williams, Gregory Strachan, Robyn G. C. Macrae, Rhoda E. Kuc, Duuamene Nyimanu, Anna L. Paterson, Sanjay Sinha, Janet J. Maguire & Anthony P. Davenport. (2021) Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sites. Scientific Reports 11:1.
Crossref
Crossref
Sally Badawi & Bassam R. Ali. (2021) ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues. Human Genomics 15:1.
Crossref
Crossref
Sonia Tamanna, Eugenie R. Lumbers, Saije K. Morosin, Sarah J. Delforce & Kirsty G. Pringle. (2021) ACE2: a key modulator of the renin-angiotensin system and pregnancy. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 321:6, pages R833-R843.
Crossref
Crossref
Mohammad Muzaffar Mir, Rashid Mir, Mushabab Ayed Abdullah Alghamdi, Badr Abdulmohsin Alsayed, Javed Iqbal Wani, Muffarah Hamid Alharthi & Abdullah M. AL-Shahrani. (2021) Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease Mortality. Journal of Personalized Medicine 11:11, pages 1098.
Crossref
Crossref
Ahmed Suleiman, Tamadher Rafaa, Ali Alrawi & Mustafa Dawood. (2021) The impact of ACE2 genetic polymorphisms (rs2106809 and rs2074192) on gender susceptibility to COVID-19 infection and recovery: A systematic review. Baghdad Journal of Biochemistry and Applied Biological Sciences 2:03, pages 167-180.
Crossref
Crossref
Mariana Guilger-Casagrande, Cecilia T. de Barros, Vitória A. N. Antunes, Daniele R. de Araujo & Renata Lima. (2021) Perspectives and Challenges in the Fight Against COVID-19: The Role of Genetic Variability. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Mahmood A. Al-Azzawi & Moustafa A. Sakr. 2021. Genetic Diversity [Working Title]. Genetic Diversity [Working Title].
HariOm Singh, Ranjana Choudhari, Vijay Nema & Abdul Arif Khan. (2021) ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease. Microbial Pathogenesis 150, pages 104621.
Crossref
Crossref
Aparna Tiwari, Auley De, Veena Pande & Abhinav Sinha. (2020) Human Angiotensin-Converting Enzyme may be under malaria selection pressure: a need to explore. Human Cell 34:1, pages 289-290.
Crossref
Crossref
Dipannita Santra, Amrita Banerjee & Smarajit Maiti. 2021. Targeting Cellular Signalling Pathways in Lung Diseases. Targeting Cellular Signalling Pathways in Lung Diseases
583
599
.
Mayank Chaudhary. (2020) COVID-19 susceptibility: potential of ACE2 polymorphisms. Egyptian Journal of Medical Human Genetics 21:1.
Crossref
Crossref
Vignesh Mariappan, Rao S. R. & Agieshkumar Balakrishna Pillai. (2020) Angiotensin‐converting enzyme 2: A protective factor in regulating disease virulence of SARS‐COV‐2. IUBMB Life 72:12, pages 2533-2545.
Crossref
Crossref
Sonia Tamanna, Vicki L. Clifton, Kym Rae, Dirk F. van Helden, Eugenie R. Lumbers & Kirsty G. Pringle. (2020) Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age. Frontiers in Physiology 11.
Crossref
Crossref
Mira Bosso, Thangavel Alphonse Thanaraj, Mohamed Abu-Farha, Muath Alanbaei, Jehad Abubaker & Fahd Al-Mulla. (2020) The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19. Molecular Therapy - Methods & Clinical Development 18, pages 321-327.
Crossref
Crossref
О.С. Павлова. (2020) Gender Features of Renin-Angiotensin-Aldosterone System in the Light of the Pandemic COVID-19. Кардиология в Беларуси:3, pages 382-389.
Crossref
Crossref
Soudeh Ghafouri-Fard, Rezvan Noroozi, Mir Davood Omrani, Wojciech Branicki, Ewelina Pośpiech, Arezou Sayad, Krzysztof Pyrc, Paweł P. Łabaj, Reza Vafaee, Mohammad Taheri & Marek Sanak. (2020) Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection. Vascular Pharmacology 130, pages 106680.
Crossref
Crossref
Christian A. Devaux, Jean-Marc Rolain & Didier Raoult. (2020) ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. Journal of Microbiology, Immunology and Infection 53:3, pages 425-435.
Crossref
Crossref
Gomaa Mostafa-Hedeab. (2020) ACE2 as Drug Target of COVID-19 Virus Treatment, Simplified Updated Review. Reports of Biochemistry and Molecular Biology 9:1, pages 97-105.
Crossref
Crossref
Justine R. Horne & Marie-Claude Vohl. (2020)
Biological plausibility for interactions between dietary fat, resveratrol,
ACE2
, and SARS-CoV illness severity
. American Journal of Physiology-Endocrinology and Metabolism 318:5, pages E830-E833.
Crossref
Crossref
Yi Luo, Cheng Liu, Tianwang Guan, Yanfang Li, Yanxian Lai, Fang Li, Haiyan Zhao, Tutiguli Maimaiti & Abudurexiti Zeyaweiding. (2018) Association of ACE2 genetic polymorphisms with
hypertension-related target organ damages in south Xinjiang. Hypertension Research 42:5, pages 681-689.
Crossref
Crossref
Hongtao Gong, Liying Mu, Tong Zhang, Xiuying Xu & Fenghe Du. (2019) Association of polymorphisms of CYP11B2 gene –344C/T and ACE gene I/D with antihypertensive response to angiotensin receptor blockers in Chinese with hypertension. Journal of Genetics 98:1.
Crossref
Crossref
Hong-Tao Gong, Li-Ying Mu, Tong Zhang, Xiu-Ying Xu & Feng-He Du. (2019) Association of mononucleotide polymorphisms of angiotensinogen gene at promoter region with antihypertensive response to angiotensin receptor blockers in hypertensive Chinese. Journal of the Renin-Angiotensin-Aldosterone System 20:1, pages 147032031982720.
Crossref
Crossref
Qi Zhang, Mingyu Cong, Ningning Wang, Xueyan Li, Hao Zhang, Keyong Zhang, Ming Jin, Nan Wu, Changchun Qiu & Jingping Li. (2018) Association of angiotensin-converting enzyme 2 gene polymorphism and enzymatic activity with essential hypertension in different gender. Medicine 97:42, pages e12917.
Crossref
Crossref
Y Y Chen, D Liu, P Zhang, J C Zhong, C J Zhang, S L Wu, Y Q Zhang, G Z Liu, M He, L J Jin & H M Yu. (2016) Impact of ACE2 gene polymorphism on antihypertensive efficacy of ACE inhibitors. Journal of Human Hypertension 30:12, pages 766-771.
Crossref
Crossref
Dan Liu, Yongyue Chen, Ping Zhang, Jiuchang Zhong, Lijun Jin, Caojin Zhang, Shuguang Lin, Shulin Wu & Huimin Yu. (2016) Association between circulating levels of ACE2-Ang-(1–7)-MAS axis and ACE2 gene polymorphisms in hypertensive patients. Medicine 95:24, pages e3876.
Crossref
Crossref
Mei Yang, Jing Zhao, Lin Xing & Li Shi. (2014) The association between angiotensin-converting enzyme 2 polymorphisms and essential hypertension risk: A meta-analysis involving 14,122 patients. Journal of the Renin-Angiotensin-Aldosterone System 16:4, pages 1240-1244.
Crossref
Crossref
Jinxin Li, Min Feng, Yanli Wang, Yaodong Li, Yanyi Zhang, Lei Li, Jian Xiong, Changzhu Lu, Bin Wang, Zuheng Cheng, Baopeng Tang & Wenquan Niu. (2014) The relationship between three X-linked genes and the risk for hypertension among northeastern Han Chinese. Journal of the Renin-Angiotensin-Aldosterone System 16:4, pages 1321-1328.
Crossref
Crossref
J. Zheng, G. Li, S. Chen, J. Bihl, J. Buck, Y. Zhu, H. Xia, E. Lazartigues, Y. Chen & J.E. Olson. (2014) Activation of the ACE2/Ang-(1–7)/Mas pathway reduces oxygen–glucose deprivation-induced tissue swelling, ROS production, and cell death in mouse brain with angiotensin II overproduction. Neuroscience 273, pages 39-51.
Crossref
Crossref
Sheila K. Patel, Elena Velkoska, Melanie Freeman, Bryan Wai, Terase F. Lancefield & Louise M. Burrell. (2014) From gene to protein—experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension. Frontiers in Physiology 5.
Crossref
Crossref